Actively Recruiting

Phase 1
Age: 18Years +
All Genders
NCT04593589

Submandibular Gland Stem Cell Transplantation

Led by University Medical Center Groningen · Updated on 2024-10-22

18

Participants Needed

1

Research Sites

346 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is a phase I safety and feasibility study to treat head and neck cancer patients with autologous salivary gland stem cell transplantation after postoperative (chemo)radiotherapy.

CONDITIONS

Official Title

Submandibular Gland Stem Cell Transplantation

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Squamous cell carcinoma (SCC) originating from the mucosa of the oral cavity
  • Primary resection of tumour including an electively or therapeutic ipsilateral neck dissection (at least levels Ib to III, including the submandibular gland)
  • Postoperative radiotherapy or chemoradiation including prophylactic or therapeutic irradiation of the contralateral side of the neck, including at least levels Ib to IV, next to irradiation of the tumour bed and ipsilateral neck
  • Age 18 years or older
  • WHO performance status 0-2
  • Written informed consent
Not Eligible

You will not qualify if you...

  • Primary (definitive) radiotherapy, with or without systemic treatment
  • Previous radiotherapy of the head and neck region (re-irradiation)
  • Positive microbiological screening for HIV types 1 and 2, hepatitis B and C virus, and Treponema pallidum
  • Presence of systemic disease known to affect salivary gland functioning (e.g., Sjögren's syndrome)
  • Known allergy to mice and gentamicin
  • History within the past five years of malignancies other than basal or squamous cell carcinoma of the skin or in situ carcinoma of the cervix
  • Females who are pregnant or lactating at entry

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

UMCG

Groningen, Netherlands

Actively Recruiting

Loading map...

Research Team

R

R.J.H.M. Steenbakkers, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here